A prospective observational cohort study

Aim This study investigated the effects of tryptophan (TRP) metabolism, kynurenine pathway (KP) and neopterin levels in heroin use disorder (HUD) in relation to neurotoxicity, treatment processes and psychiatric recovery. Method The study groups consisted of patients with HUD who sought treatment at the hospital and received treatment, and a healthy control (C) group. The levels of neopterin, tryptophan and kynurenine in the participants’ serum were determined, and the pre- and post-treatment results in the groups were compared with the controls. Results Neopterin levels, reflecting immune system activation, were observed to decrease in HUD group after treatment (p = 0.021). Similarly, a decrease in levels of tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine, was also detected after treatment (p 0.05). The total scores of the Addiction Profile Index (API-K), which measures the severity of addiction, decreased significantly after treatment (p < 0.001). At the same time, improvement was observed in the general symptom level (GSI) and all subscales (including depression, anxiety, obsessive-compulsive disorders, and somatization) of the Symptom Checklist-90-Revised (SCL-90-R) scale, which assesses general psychopathology. Regression analyses revealed that the two strongest factors negatively affecting treatment success in the HUD group were duration of use (p = 0.028) and high neopterin levels (p = 0.020). Conclusion This study highlights the critical role of immunological and neuroinflammatory processes in the success of HUD treatment. The findings indicate that biochemical recovery progresses in parallel with psychiatric recovery during treatment, and that changes in the KYN/TRP ratio and IL-6 levels have strong diagnostic and prognostic value. Neopterin, kynurenine, and tryptophan, on the other hand, have moderate prognostic value

Cohort · Cohort study · Heroin · Kynurenine · Kynurenine pathway · Neopterin · Observational study · Prospective cohort study · Neurotransmitter Receptor Influence on Behavior · Schizophrenia research and treatment · Tryptophan and brain disorders

• The kynurenine and serotonin pathway, neopterin and biopterin in depressed children and adolescents

  Open Access•Lucia Ilavská, Marcela Morvová et al.•Frontiers in Psychiatry•2024

  Add to list

• Integrated hepatitis C treatment is associated with improved retention and success in outpatient treatment for opioid use disorder at a private clinic

  Open Access•Phyllis Losikoff, Jordon D Bosse et al.•Frontiers in Psychiatry•2022

  Add to list